Mineralys Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Mineralys Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mineralys Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mineralys Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $861k | 23k | 37.92 |
| 2025-06-30 | $325k | 24k | 13.53 |
| 2025-03-31 | $267k | 17k | 15.88 |
| 2024-12-31 | $211k | 17k | 12.31 |
| 2024-09-30 | $207k | 17k | 12.11 |
| 2024-06-30 | $200k | 17k | 11.70 |
| 2023-12-31 | $98k | 11k | 8.60 |
| 2023-09-30 | $67k | 7.1k | 9.51 |
| 2023-06-30 | $120k | 7.1k | 17.05 |
| 2023-03-31 | $111k | 7.1k | 15.66 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors